This weekly email delivers timely College news and a curated roundup of key articles and resources to keep you current, including breaking news, anecdotes from esteemed practitioners, insight into matters that affect the profession, and direct access to online education tools.
- Show all
- A Word from the President
- Annual Meeting
- Coding Conundrums
- Community Advantage
- Editorials from the Executive Medical Director
- High-five
- House of Delegates
- In Memoriam
- In My Opinion
- Medicare
- Practice Excellence
- Practice Management Advantage
- Spotlight on Annals
- Summation of COVID-19 Federal Responses
- Washington Perspectives
- Show all
- A/I Action
- Advocacy Alert
- Advocacy Resources
- AllergyWatch
- Annals
- Annual Meeting
- CA2PER Program
- College Advantage
- Committees
- Course
- COVID-19
- Disaster Resources
- Education
- Event
- Foundation
- From College Leadership
- Gold Headed Cane
- History
- House of Delegates
- Leadership
- Member benefit
- New Allergists
- News
- Opinion
- Pathways to Practice
- Patient Brochures
- Payer Education Campaign
- Resources
- Survey
- Time For An Allergist
- Uncategorized
- Webinar
- Women in Allergy
2026 HIPAA updates
This update provides members with a high-level overview with specific considerations for allergy and immunology practices.
Virtual direct supervision permanent for Medicare
Good news for allergy practices: virtual direct supervision is now permanent under Medicare for many allergy services.
Read about predictions for urticaria treatment and lung function
The March 2026 issue of Annals is focused on predictions – predictions for urticaria treatment and lung function.
Helping you and your patients stay updated
Here are some highlights from the resourceful ACAAI patient and member websites for you and your patients.
Advocacy Council fights for you on Capitol Hill
Members of the ACAAI Advocacy Council were on Capitol Hill fighting for issues important to allergy practices last week.
New proposed Medicare drug pricing models are unveiled
The College emphasizes that while fair pricing is essential, policies mustn't compromise drug availability or stifle research into new therapies.
We’re defending and empowering allergists
The ACAAI is the only allergy organization backed by Washington-based experts and consultants whose primary focus is allergy/immunology.
AllergyTalk is now a vodcast
You’ve heard their voices and trusted their expertise. Now it’s time to see the conversation unfold in the first video podcast episode.
The new era of health AI: what allergists need to know
For the first time, large scale AI platforms are being built explicitly for health care delivery rather than adapted from consumer tools.
